The DOI matches its Crossref record; 195 of the 195 references it cites were found in a registry or an index.
Mechanisms of Action of Antiseizure Drugs and the Ketogenic Diet
Open accessAbstract
Antiseizure drugs (ASDs), also termed antiepileptic drugs, are the main form of symptomatic treatment for people with epilepsy, but not all patients become free of seizures. The ketogenic diet is one treatment option for drug-resistant patients. Both types of therapy exert their clinical effects through interactions with one or more of a diverse set of molecular targets in the brain. ASDs act by modulation of voltage-gated ion channels, including sodium, calcium, and potassium channels; by enhancement of γ-aminobutyric acid (GABA)-mediated inhibition through effects on GABAA receptors, the GABA transporter 1 (GAT1) GABA uptake transporter, or GABA transaminase; through interactions with elements of the synaptic release machinery, including synaptic vesicle 2A (SV2A) and α2δ; or by blockade of ionotropic glutamate receptors, including α-amino-3-hydroxy-5-methyl-4-isoxazole-propionate (AMPA) receptors. The ketogenic diet leads to increases in circulating ketones, which may contribute to the efficacy in treating pharmacoresistant seizures. Production in the brain of inhibitory mediators, such as adenosine, or ion channel modulators, such as polyunsaturated fatty acids, may also play a role. Metabolic effects, including diversion from glycolysis, are a further postulated mechanism. For some ASDs and the ketogenic diet, effects on multiple targets may contribute to activity. Better understanding of the ketogenic diet will inform the development of improved drug therapies to treat refractory seizures.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Suppression of Oxidative Stress by β-Hydroxybutyrate, an Endogenous Histone Deacetylase Inhibitor
Shimazu, T., Hirschey, M. D., Newman, J., He, W., Shirakawa, K., Le Moan, N., Grueter, C. A., Lim, H., Saunders, L. R., Stevens, R. D., et al. (2013) · Science · doi:10.1126/science.1227166 · Cited by 1,777
The Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
The ketogenic diet for the treatment of childhood epilepsy: a randomised controlled trial
Neal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., Whitney, A., & Cross, J. H. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70092-9 · Cited by 1,224
Kimura, I., Inoue, D., Maeda, T., Hara, T., Ichimura, A., Miyauchi, S., Kobayashi, M., Hirasawa, A., & Tsujimoto, G. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1016088108 · Cited by 1,106
GABAA receptors: Subtypes provide diversity of function and pharmacology
Olsen, R. W., & Sieghart, W. (2009) · Neuropharmacology · doi:10.1016/j.neuropharm.2008.07.045 · Cited by 982
A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family
Charlier, C., Singh, N. A., Ryan, S. G., Lewis, T. B., Reus, B. E., Leach, R. J., & Leppert, M. (1998) · Nature Genetics · doi:10.1038/ng0198-53 · Cited by 937
Talley, E. M., Cribbs, L. L., Lee, J.-H., Daud, A., Perez-Reyes, E., & Bayliss, D. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-01895.1999 · Cited by 790
Low-Threshold Calcium Currents in Central Nervous System Neurons
Huguenard, J. R. (1996) · Annual Review of Physiology · doi:10.1146/annurev.ph.58.030196.001553 · Cited by 763
Monocarboxylate transporters in the central nervous system: distribution, regulation and function
Pierre, K., & Pellerin, L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03168.x · Cited by 744
Overview of the voltage-gated sodium channel family
Yu (2003) · Genome biology · doi:10.1186/gb-2003-4-3-207 · Cited by 694
Toward clinical application of the Keap1-Nrf2 pathway
Suzuki, T., Motohashi, H., & Yamamoto, M. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.005 · Cited by 680
Brown, D. A., & Passmore, G. M. (2009) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00111.x · Cited by 676
L??scher, W. (2002) · CNS Drugs · doi:10.2165/00023210-200216100-00003 · Cited by 664
Self-citationRogawski, M. A., & Porter, R. J. (1990) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)00046-8 · Cited by 656
Self-citationTHE CONCISE GUIDE TO PHARMACOLOGY 2019/20: Ion channels
Alexander, S. P. H., Mathie, A., Peters, J. A., Veale, E. L., Striessnig, J., Kelly, E., Armstrong, J. F., Faccenda, E., Harding, S. D., Pawson, A. J., et al. (2019) · British Journal of Pharmacology · doi:10.1111/bph.14749 · Cited by 606
Mitochondrial biogenesis in the anticonvulsant mechanism of the ketogenic diet
Bough, K. J., Wetherington, J., Hassel, B., Pare, J. F., Gawryluk, J. W., Greene, J. G., Shaw, R., Smith, Y., Geiger, J. D., & Dingledine, R. J. (2006) · Annals of Neurology · doi:10.1002/ana.20899 · Cited by 597
Field, M. J., Cox, P. J., Stott, E., Melrose, H., Offord, J., Su, T.-Z., Bramwell, S., Corradini, L., England, S., Winks, J., et al. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0409066103 · Cited by 591
Pathophysiological mechanisms of genetic absence epilepsy in the rat
Danober, L., Deransart, C., Depaulis, A., Vergnes, M., & Marescaux, C. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00091-9 · Cited by 584
Taylor, C. P., Angelotti, T., & Fauman, E. (2007) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.09.008 · Cited by 565
Wheless, J. W. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01821.x · Cited by 533
Characterization of ethosuximide reduction of low‐threshold calcium current in thalamic neurons
Coulter, D. A., Huguenard, J. R., & Prince, D. A. (1989) · Annals of Neurology · doi:10.1002/ana.410250610 · Cited by 504
Ragsdale, D. S., McPhee, J. C., Scheuer, T., & Catterall, W. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.17.9270 · Cited by 498
Localization and Targeting of Voltage-Dependent Ion Channels in Mammalian Central Neurons
Vacher, H., Mohapatra, D. P., & Trimmer, J. S. (2008) · Physiological Reviews · doi:10.1152/physrev.00002.2008 · Cited by 488
Maalouf, M., Sullivan, P. G., Davis, L., Kim, D. Y., & Rho, J. M. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2006.11.065 · Cited by 477
Self-citationMolecular Targets for Antiepileptic Drug Development
Meldrum, B. S., & Rogawski, M. A. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 468
Self-citationVoltage-gated sodium channels as therapeutic targets in epilepsy and other neurological disorders
Mantegazza, M., Curia, G., Biagini, G., Ragsdale, D. S., & Avoli, M. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70059-4 · Cited by 455
Garriga-Canut, M., Schoenike, B., Qazi, R., Bergendahl, K., Daley, T. J., Pfender, R. M., Morrison, J. F., Ockuly, J., Stafstrom, C., Sutula, T., et al. (2006) · Nature Neuroscience · doi:10.1038/nn1791 · Cited by 450
Neuroprotective and disease-modifying effects of the ketogenic diet
Gasior, M., Rogawski, M. A., & Hartman, A. L. (2006) · Behavioural Pharmacology · doi:10.1097/00008877-200609000-00009 · Cited by 445
Self-citationThe Ketogenic Diet as a Treatment Paradigm for Diverse Neurological Disorders
Stafstrom, C. E., & Rho, J. M. (2012) · Frontiers in Pharmacology · doi:10.3389/fphar.2012.00059 · Cited by 438
Self-citationNeal, E. G., Chaffe, H., Schwartz, R. H., Lawson, M. S., Edwards, N., Fitzsimmons, G., Whitney, A., & Cross, J. H. (2009) · Epilepsia · doi:10.1111/j.1528-1167.2008.01870.x · Cited by 436
Hanada, T., Hashizume, Y., Tokuhara, N., Takenaka, O., Kohmura, N., Ogasawara, A., Hatakeyama, S., Ohgoh, M., Ueno, M., & Nishizawa, Y. (2011) · Epilepsia · doi:10.1111/j.1528-1167.2011.03109.x · Cited by 411
The ketogenic diet increases mitochondrial uncoupling protein levels and activity
Sullivan, P. G., Rippy, N. A., Dorenbos, K., Concepcion, R. C., Agarwal, A. K., & Rho, J. M. (2004) · Annals of Neurology · doi:10.1002/ana.20062 · Cited by 411
Self-citationMetabolic Control of Vesicular Glutamate Transport and Release
Juge, N., Gray, J. A., Omote, H., Miyaji, T., Inoue, T., Hara, C., Uneyama, H., Edwards, R. H., Nicoll, R. A., & Moriyama, Y. (2010) · Neuron · doi:10.1016/j.neuron.2010.09.002 · Cited by 400
Medium‐chain triglycerides as a therapy for intractable childhood epilepsy
Huttenlocher, P. R., Wilbourn, A. J., & Signore, J. M. (1971) · Neurology · doi:10.1212/wnl.21.11.1097 · Cited by 399
Mechanisms of Action of Antiepileptic Drugs
Czapinski, P., Blaszczyk, B., & Czuczwar, S. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026053386962 · Cited by 382
Huttenlocher, P. R. (1976) · Pediatric Research · doi:10.1203/00006450-197605000-00006 · Cited by 375
Gu, N., Vervaeke, K., Hu, H., & Storm, J. F. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2005.086835 · Cited by 363
Functional biology of the α2δ subunits of voltage-gated calcium channels
Davies, A., Hendrich, J., Van Minh, A. T., Wratten, J., Douglas, L., & Dolphin, A. C. (2007) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2007.03.005 · Cited by 360
α2δ expression sets presynaptic calcium channel abundance and release probability
Hoppa, M. B., Lana, B., Margas, W., Dolphin, A. C., & Ryan, T. A. (2012) · Nature · doi:10.1038/nature11033 · Cited by 358
Gibbs, J. W., Sombati, S., DeLorenzo, R. J., & Coulter, D. A. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02164.x · Cited by 348
Diverse mechanisms of antiepileptic drugs in the development pipeline
Rogawski, M. A. (2006) · Epilepsy Research · doi:10.1016/j.eplepsyres.2006.02.004 · Cited by 340
Self-citationCortical and subcortical networks in human secondarily generalized tonic–clonic seizures
Blumenfeld, H., Varghese, G. I., Purcaro, M. J., Motelow, J. E., Enev, M., McNally, K. A., Levin, A. R., Hirsch, L. J., Tikofsky, R., Zubal, I. G., et al. (2009) · Brain · doi:10.1093/brain/awp028 · Cited by 331
Selection of Antiepileptic Drug Polytherapy Based on Mechanisms of Action: The Evidence Reviewed
Deckers, C. L. P., Czuczwar, S. J., Hekster, Y. A., Kewser, A., Kubova, H., Meinardi, H., Patsalos, P. N., Renier, W. O., & Van Rijn, C. M. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb00111.x · Cited by 331
Gunthorpe, M. J., Large, C. H., & Sankar, R. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03365.x · Cited by 319
Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb06047.x · Cited by 316
A ketogenic diet suppresses seizures in mice through adenosine A1 receptors
Masino, S. A., Li, T., Theofilas, P., Sandau, U. S., Ruskin, D. N., Fredholm, B. B., Geiger, J. D., Aronica, E., & Boison, D. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57813 · Cited by 308
Polyunsaturated fatty acids modulate sodium and calcium currents in CA1 neurons.
Vreugdenhil, M., Bruehl, C., Voskuyl, R. A., Kang, J. X., Leaf, A., & Wadman, W. J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12559 · Cited by 304
Cerebral ketone body metabolism
Morris, A. A. M. (2005) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-005-5518-0 · Cited by 298
Ketogenic Diet Metabolites Reduce Firing in Central Neurons by Opening K ATP Channels
Ma, W., Berg, J., & Yellen, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.0132-07.2007 · Cited by 294
The effect of gabapentin on brain gamma‐aminobutyric acid in patients with epilepsy
Petroff, O. A. C., Rothman, D. L., Behar, K. L., Lamoureux, D., & Mattson, R. H. (1996) · Annals of Neurology · doi:10.1002/ana.410390114 · Cited by 285
Reddy, D. S., & Rogawski, M. A. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03795.2002 · Cited by 279
Self-citationStahl, S. M., Porreca, F., Taylor, C. P., Cheung, R., Thorpe, A. J., & Clair, A. (2013) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2013.04.001 · Cited by 277
Steinhoff, B. J., Ben‐Menachem, E., Ryvlin, P., Shorvon, S., Kramer, L., Satlin, A., Squillacote, D., Yang, H., Zhu, J., & Laurenza, A. (2013) · Epilepsia · doi:10.1111/epi.12212 · Cited by 268
Thompson, S. M., & Gahwiler, B. H. (1992) · Journal of Neurophysiology · doi:10.1152/jn.1992.67.6.1698 · Cited by 263
Mitochondrial involvement and oxidative stress in temporal lobe epilepsy
Rowley, S., & Patel, M. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.02.002 · Cited by 258
Mitochondrial uncoupling protein‐2 protects the immature brain from excitotoxic neuronal death
Sullivan, P. G., Dubé, C., Dorenbos, K., Steward, O., & Baram, T. Z. (2003) · Annals of Neurology · doi:10.1002/ana.10543 · Cited by 251
Persistent Sodium Current and Its Role in Epilepsy
Stafstrom, C. E. (2007) · Epilepsy Currents · doi:10.1111/j.1535-7511.2007.00156.x · Cited by 249
The ketogenic diet increases mitochondrial glutathione levels
Jarrett, S. G., Milder, J. B., Liang, L., & Patel, M. (2008) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2008.05460.x · Cited by 244
The on-off switches of the mitochondrial uncoupling proteins
Azzu, V., & Brand, M. D. (2010) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2009.11.001 · Cited by 239
AMPA receptors as a molecular target in epilepsy therapy
Rogawski, M. A. (2013) · Acta Neurologica Scandinavica · doi:10.1111/ane.12099 · Cited by 231
Self-citationT-type calcium channels mediate the transition between tonic and phasic firing in thalamic neurons.
Suzuki, S., & Rogawski, M. A. (1989) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.86.18.7228 · Cited by 217
Self-citationBlock of Cloned Human T-Type Calcium Channels by Succinimide Antiepileptic Drugs
Gomora, J. C., Daud, A. N., Weiergräber, M., & Perez-Reyes, E. (2001) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12522-9 · Cited by 216
Acute oxidative stress and systemic Nrf2 activation by the ketogenic diet
Milder, J. B., Liang, L.-P., & Patel, M. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.05.030 · Cited by 212
The α2δ subunits of voltage-gated calcium channels
Dolphin, A. C. (2013) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2012.11.019 · Cited by 210
Current understanding of the mechanism of action of the antiepileptic drug lacosamide
Rogawski, M. A., Tofighy, A., White, H. S., Matagne, A., & Wolff, C. (2015) · Epilepsy Research · doi:10.1016/j.eplepsyres.2014.11.021 · Cited by 208
Self-citationHow theories evolved concerning the mechanism of action of barbiturates
Löscher, W., & Rogawski, M. A. (2012) · Epilepsia · doi:10.1111/epi.12025 · Cited by 207
Self-citationEarly treatment suppresses the development of spike‐wave epilepsy in a rat model
Blumenfeld, H., Klein, J. P., Schridde, U., Vestal, M., Rice, T., Khera, D. S., Bashyal, C., Giblin, K., Paul‐Laughinghouse, C., Wang, F., et al. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2007.01458.x · Cited by 206
Ketone bodies are protective against oxidative stress in neocortical neurons
Kim, D. Y., Davis, L. M., Sullivan, P. G., Maalouf, M., Simeone, T. A., Brederode, J. V., & Rho, J. M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04483.x · Cited by 205
Self-citationThe excitatory amino acid antagonist d-CPP-ene (SDZ EAA-494) in patients with epilepsy
Sveinbjornsdottir, S., Sander, J. W. A. S., Upton, D., Thompson, P. J., Patsalos, P. N., Hirt, D., Emre, M., Lowe, D., & Duncan, J. S. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90031-2 · Cited by 200
Sahara, S., Yanagawa, Y., O'Leary, D. D. M., & Stevens, C. F. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6412-11.2012 · Cited by 198
Sofia, R. D. (1994) · Annals of Neurology · doi:10.1002/ana.410360423 · Cited by 194
Gabapentin increases aminooxyacetic acid-induced GABA accumulation in several regions of rat brain
Löscher, W., Hönack, D., & Taylor, C. P. (1991) · Neuroscience Letters · doi:10.1016/0304-3940(91)90249-s · Cited by 193
Self-citationTurner, J. P., & Salt, T. E. (1998) · The Journal of Physiology · doi:10.1111/j.1469-7793.1998.829bj.x · Cited by 191
Ketone bodies mediate antiseizure effects through mitochondrial permeability transition
Kim, D. Y., Simeone, K. A., Simeone, T. A., Pandya, J. D., Wilke, J. C., Ahn, Y., Geddes, J. W., Sullivan, P. G., & Rho, J. M. (2015) · Annals of Neurology · doi:10.1002/ana.24424 · Cited by 189
Self-citationDirect activation of GABAA receptors by barbiturates in cultured rat hippocampal neurons.
Rho, J. M., Donevan, S. D., & Rogawski, M. A. (1996) · The Journal of Physiology · doi:10.1113/jphysiol.1996.sp021784 · Cited by 188
Self-citationSomatodendritic Kv7/KCNQ/M Channels Control Interspike Interval in Hippocampal Interneurons
Lawrence, J. J., Saraga, F., Churchill, J. F., Statland, J. M., Travis, K. E., Skinner, F. K., & McBain, C. J. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3521-06.2006 · Cited by 187
Electrophysiology and beyond: Multiple roles of Na+ channel β subunits in development and disease
Patino, G. A., & Isom, L. L. (2010) · Neuroscience Letters · doi:10.1016/j.neulet.2010.06.050 · Cited by 183
Clinical Pharmacology and Mechanism of Action of Zonisamide
Biton, V. (2007) · Clinical Neuropharmacology · doi:10.1097/wnf.0b013e3180413d7d · Cited by 180
Martire, M., Castaldo, P., D'Amico, M., Preziosi, P., Annunziato, L., & Taglialatela, M. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3143-03.2004 · Cited by 175
Elevated polyunsaturated fatty acids in blood serum obtained from children on the ketogenic diet
Fraser, D. D., Whiting, S., Andrew, R. D., Macdonald, E. A., Musa–Veloso, K., & Cunnane, S. C. (2003) · Neurology · doi:10.1212/01.wnl.0000049974.74242.c6 · Cited by 174
Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy
Löscher, W. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(97)00092-0 · Cited by 174
Self-citationHu, H., Vervaeke, K., & Storm, J. F. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4463-06.2007 · Cited by 172
Omega-3 fatty acid supplementation in patients with chronic epilepsy: A randomized trial
Yuen, A. W. C., Sander, J. W., Fluegel, D., Patsalos, P. N., Bell, G. S., Johnson, T., & Koepp, M. J. (2005) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2005.04.014 · Cited by 172
Basic neurochemistry : principles of molecular, cellular and medical neurobiology
Brady, S. T., Siegel, G. J., Albers, R. W., & Price, D. L. (2012) · Cited by 171
Diet Enriched with Omega‐3 Fatty Acids Alleviates Convulsion Symptoms in Epilepsy Patients
Schlanger, S., Shinitzky, M., & Yam, D. (2002) · Epilepsia · doi:10.1046/j.1528-1157.2002.13601.x · Cited by 169
Won, Y., Lu, V. B., Puhl, H. L., & Ikeda, S. R. (2013) · Journal of Neuroscience · doi:10.1523/jneurosci.3102-13.2013 · Cited by 168
Liu, Y.-M., & Wang, H.-S. (2013) · Biomedical Journal · doi:10.4103/2319-4170.107154 · Cited by 166
Anticonvulsant and antiepileptic actions of 2‐deoxy‐D‐glucose in epilepsy models
Stafstrom, C. E., Ockuly, J. C., Murphree, L., Valley, M. T., Roopra, A., & Sutula, T. P. (2009) · Annals of Neurology · doi:10.1002/ana.21603 · Cited by 166
Mechanisms of Ketogenic Diet Action
Masino, S. A., & Rho, J. M. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0078 · Cited by 164
Self-citationDahlin, M., Elfving, Å., Ungerstedt, U., & Åmark, P. (2005) · Epilepsy Research · doi:10.1016/j.eplepsyres.2005.03.008 · Cited by 163
Anticonvulsant properties of acetone, a brain ketone elevated by the ketogenic diet
Likhodii, S. S., Serbanescu, I., Cortez, M. A., Murphy, P., Snead, O. C., & Burnham, W. M. (2003) · Annals of Neurology · doi:10.1002/ana.10634 · Cited by 158
Yue, C., & Yaari, Y. (2006) · Journal of Neurophysiology · doi:10.1152/jn.01333.2005 · Cited by 156
Wu, Y., Wang, W., & Richerson, G. B. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00856.2002 · Cited by 155
Single KATP Channel Opening in Response to Action Potential Firing in Mouse Dentate Granule Neurons
Tanner, G. R., Lutas, A., Martínez‐François, J. R., & Yellen, G. (2011) · Journal of Neuroscience · doi:10.1523/jneurosci.5951-10.2011 · Cited by 154
Topiramate as an Inhibitor of Carbonic Anhydrase Isoenzymes
Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000) · Epilepsia · doi:10.1111/j.1528-1157.2000.tb02169.x · Cited by 151
Neuronal–glial interactions in rats fed a ketogenic diet
Melø, T. M., Nehlig, A., & Sonnewald, U. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2005.12.037 · Cited by 150
Molecular Pharmacodynamics, Clinical Therapeutics, and Pharmacokinetics of Topiramate
Shank, R. P., & Maryanoff, B. E. (2008) · CNS Neuroscience & Therapeutics · doi:10.1111/j.1527-3458.2008.00041.x · Cited by 148
Response of brain amino acid metabolism to ketosis
Yudkoff, M., Daikhin, Y., Nissim, I., Horyn, O., Lazarow, A., Luhovyy, B. L., Wehrli, S. L., & Nissim, I. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.04.014 · Cited by 146
Ketone bodies do not directly alter excitatory or inhibitory hippocampal synaptic transmission
Thio, L. L., Wong, M. L., & Yamada, K. A. (2000) · Neurology · doi:10.1212/wnl.54.2.325 · Cited by 146
Yamaguchi, S., Donevan, S. D., & Rogawski, M. A. (1993) · Epilepsy Research · doi:10.1016/0920-1211(93)90054-b · Cited by 143
Self-citationTzingounis, A. V., Heidenreich, M., Kharkovets, T., Spitzmaul, G. F., Jensen, H. S., Nicoll, R. A., & Jentsch, T. J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1004644107 · Cited by 141
Seizure control by ketogenic diet-associated medium chain fatty acids
Chang, P., Terbach, N., Plant, N. J., Chen, P. E., Walker, M. C., & Williams, R. S. B. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.11.004 · Cited by 141
Brain glutathione levels in patients with epilepsy measured by in vivo 1 H-MRS
Mueller, S. G., Trabesinger, A. H., Boesiger, P., & Wieser, H. G. (2001) · Neurology · doi:10.1212/wnl.57.8.1422 · Cited by 139
Polyunsaturated fatty acids and epilepsy
Taha, A. Y., Burnham, W. M., & Auvin, S. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02654.x · Cited by 138
Absence seizures: A review of recent reports with new concepts
Hughes, J. R. (2009) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2009.06.007 · Cited by 137
Ketosis and the Ketogenic Diet, 2010: Advances in Treating Epilepsy and Other Disorders
Freeman, J. M., & Kossoff, E. H. (2010) · Advances in Pediatrics · doi:10.1016/j.yapd.2010.08.003 · Cited by 137
Margolis, J. M., Chu, B. C., Wang, Z. J., Copher, R. M., & Cavazos, J. E. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.808 · Cited by 136
Vervaeke, K., Gu, N., Agdestein, C., Hu, H., & Storm, J. F. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.111336 · Cited by 135
Ethosuximide: From Bench to Bedside
Gören, M. Z., & Onat, F. (2007) · CNS Drug Reviews · doi:10.1111/j.1527-3458.2007.00009.x · Cited by 134
Nrf2 defense pathway: Experimental evidence for its protective role in epilepsy
Mazzuferi, M., Kumar, G., van Eyll, J. M., Danis, B., Foerch, P., & Kaminski, R. M. (2013) · Annals of Neurology · doi:10.1002/ana.23940 · Cited by 132
Waldmeier, P. C., Baumann, P. A., Wicki, P., Feldtrauer, J.-J., Stierlin, C., & Schmutz, M. (1995) · Neurology · doi:10.1212/wnl.45.10.1907 · Cited by 128
Dezsi, G., Öztürk, E., Stanić, D., Powell, K. L., Blumenfeld, H., O'Brien, T. J., & Jones, N. C. (2013) · Epilepsia · doi:10.1111/epi.12118 · Cited by 127
Sodium channels and the neurobiology of epilepsy
Oliva, M., Berkovic, S. F., & Petrou, S. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2012.03631.x · Cited by 124
Rundfeldt, C., & Netzer, R. (2011) · Arzneimittelforschung · doi:10.1055/s-0031-1300346 · Cited by 118
Fructose-1,6-Bisphosphate Has Anticonvulsant Activity in Models of Acute Seizures in Adult Rats
Lian, X., Khan, F. A., & Stringer, J. L. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.3163-07.2007 · Cited by 115
A randomized trial of polyunsaturated fatty acids for refractory epilepsy
Bromfield, E. B., Dworetzky, B. A., Hurwitz, S., Eluri, Z., Lane, L., Replansky, S., & Mostofsky, D. I. (2008) · Epilepsy & Behavior · doi:10.1016/j.yebeh.2007.09.011 · Cited by 115
Paradoxical Reduction of Synaptic Inhibition by Vigabatrin
Overstreet, L. S., & Westbrook, G. L. (2001) · Journal of Neurophysiology · doi:10.1152/jn.2001.86.2.596 · Cited by 115
Ketones prevent synaptic dysfunction induced by mitochondrial respiratory complex inhibitors
Kim, D. Y., Vallejo, J., & Rho, J. M. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06728.x · Cited by 113
Self-citationTatulian, L., & Brown, D. A. (2003) · The Journal of Physiology · doi:10.1113/jphysiol.2003.039842 · Cited by 113
Meehan, A. L., Yang, X., McAdams, B. D., Yuan, L., & Rothman, S. M. (2011) · Journal of Neurophysiology · doi:10.1152/jn.00279.2011 · Cited by 112
ffrench-Mullen, J. M. H., Barker, J. L., & Rogawski, M. A. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03211.1993 · Cited by 110
Self-citationOmega-3 fatty acids and traumatic neurological injury: from neuroprotection to neuroplasticity?
Michael-Titus, A. T., & Priestley, J. V. (2013) · Trends in Neurosciences · doi:10.1016/j.tins.2013.10.005 · Cited by 108
Mantis, J. G., Centeno, N. A., Todorova, M. T., McGowan, R., & Seyfried, T. N. (2004) · Nutrition & Metabolism · doi:10.1186/1743-7075-1-11 · Cited by 108
Otto, J. F., Kimball, M. M., & Wilcox, K. S. (2002) · Molecular Pharmacology · doi:10.1124/mol.61.4.921 · Cited by 105
Mechanisms of ketogenic diet action
Masino, S. A., & Rho, J. M. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02871.x · Cited by 103
Self-citationPascual, J. M., Liu, P., Mao, D., Kelly, D. I., Hernández, A., Sheng, M., Good, L. B., Ma, Q., Marin‐Valencia, I., Zhang, X., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2014.1584 · Cited by 101
THE KETOGENIC DIET IN THE TREATMENT OF EPILEPSY
PETERMAN, M. G. (1924) · American journal of diseases of children · doi:10.1001/archpedi.1924.04120190031004 · Cited by 101
Low threshold T ‐type calcium channels as targets for novel epilepsy treatments
Powell, K. L., Cain, S. M., Snutch, T. P., & O'Brien, T. J. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12205 · Cited by 100
Zilles, K., Qü, M., Köhling, R., & Speckmann, E. ‐. (1999) · Neuroscience · doi:10.1016/s0306-4522(99)00392-9 · Cited by 97
3-Alkyl GABA and 3-alkylglutamic acid analogues: two new classes of anticonvulsant agents
Taylor, C. P., Vartanian, M. G., Andruszkiewicz, R., et al. (1992) · Epilepsy Research · doi:10.1016/0920-1211(92)90044-t · Cited by 96
Generalized Epileptic Disorders: An Update
Avoli, M., Rogawski, M. A., & AVANZINI, G. (2001) · Epilepsia · doi:10.1046/j.1528-1157.2001.39800.x · Cited by 94
Self-citationSohal, V. S., Keist, R., Rudolph, U., & Huguenard, J. R. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-09-03649.2003 · Cited by 94
Silverman, R. B., Andruszkiewicz, R., Nanavati, S. M., Taylor, C. P., & Vartanian, M. G. (1991) · Journal of Medicinal Chemistry · doi:10.1021/jm00111a053 · Cited by 92
Kaminski, R. M., Rogawski, M. A., & Klitgaard, H. (2014) · Neurotherapeutics · doi:10.1007/s13311-014-0266-1 · Cited by 90
Self-citationAnticonvulsant effects of a triheptanoin diet in two mouse chronic seizure models
Willis, S., Stoll, J., Sweetman, L., & Borges, K. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2010.07.017 · Cited by 89
Petroff, O. A. C., Behar, K. L., Mattson, R. H., & Rothman, D. L. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67062399.x · Cited by 85
Caloric restriction augments brain glutamic acid decarboxylase‐65 and ‐67 expression
Cheng, C. M., Hicks, K. C., Wang, J., Eagles, D. A., & Bondy, C. A. (2004) · Journal of Neuroscience Research · doi:10.1002/jnr.20144 · Cited by 85
Löscher, W., Jäckel, R., & Müller, F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90389-0 · Cited by 82
Self-citationChang, P., Orabi, B., Deranieh, R. M., Dham, M., Hoeller, O., Shimshoni, J. A., Yagen, B., Bialer, M., Greenberg, M. L., Walker, M. C., et al. (2011) · Disease Models & Mechanisms · doi:10.1242/dmm.008029 · Cited by 79
Long‐term seizure remission in childhood absence epilepsy: Might initial treatment matter?
Berg, A. T., Levy, S. R., Testa, F. M., & Blumenfeld, H. (2014) · Epilepsia · doi:10.1111/epi.12551 · Cited by 77
Kapetanović, I. M., Yonekawa, W. D., & Kupferberg, H. J. (1995) · Epilepsy Research · doi:10.1016/0920-1211(95)00050-x · Cited by 76
Löscher, W., Hönack, D., & Bloms‐Funke, P. (1996) · Brain Research · doi:10.1016/0006-8993(96)00587-2 · Cited by 75
Self-citationTaha, A. Y., Ryan, M. A., & Cunnane, S. C. (2005) · Metabolism · doi:10.1016/j.metabol.2005.03.018 · Cited by 74
Broicher, T., Seidenbecher, T., Meuth, P., Munsch, T., Meuth, S. G., Kanyshkova, T. G., Pape, H., & Budde, T. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.05.030 · Cited by 74
Borges, K., & Sonnewald, U. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.05.023 · Cited by 72
Treatment of Infantile Spasms: Emerging Insights From Clinical and Basic Science Perspectives
Stafstrom, C. E., Arnason, B. G. W., Baram, T. Z., Catania, A., Cortez, M. A., Glauser, T. A., Pranzatelli, M. R., Riikonen, R., Rogawski, M. A., Shinnar, S., et al. (2011) · Journal of Child Neurology · doi:10.1177/0883073811413129 · Cited by 70
Self-citationSchousboe, A., Madsen, K. K., Barker‐Haliski, M. L., & White, H. S. (2014) · Neurochemical Research · doi:10.1007/s11064-014-1263-9 · Cited by 69
Chang, P., Zuckermann, A. M. E., Williams, S., Close, A. J., Cano‐Jaimez, M., McEvoy, J. P., Spencer, J., Walker, M. C., & Williams, R. S. B. (2014) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.114.218768 · Cited by 68
Mathern, G. W., Pretorius, J. K., Mendoza, D., Lozada, A., Leite, J. P., Chimelli, L. M. C., Fried, I., Sakamoto, A. C., Assirati, J. A., & Adelson, P. D. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199806000-00008 · Cited by 68
Do Structural Changes in GABA Neurons Give Rise to the Epileptic State?
Houser, C. R. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-94-017-8914-1_12 · Cited by 66
Maalouf, M., & Rho, J. M. (2008) · Journal of Neuroscience Research · doi:10.1002/jnr.21782 · Cited by 66
Self-citationAnticonvulsant and proconvulsant actions of 2‐deoxy‐ d ‐glucose
Ga̧sior, M., Yankura, J., Hartman, A. L., French, A., & Rogawski, M. A. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02593.x · Cited by 64
Self-citation4‐Aminobutyrate aminotransferase (GABA‐transaminase) deficiency
Medina‐Kauwe, L. K., Tobin, A. J., Meırleır, L. D., et al. (1999) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005500122231 · Cited by 64
Levetiracetam has an activity‐dependent effect on inhibitory transmission
Meehan, A. L., Yang, X., Yuan, L., & Rothman, S. M. (2012) · Epilepsia · doi:10.1111/j.1528-1167.2011.03392.x · Cited by 62
Porta, N., Vallée, L., Lecointe, C., Bouchaert, E., Staels, B., Bordet, R., & Auvin, S. (2008) · Epilepsia · doi:10.1111/j.1528-1167.2008.01901.x · Cited by 60
Ga̧sior, M., French, A., Joy, M. T., Tang, R. S., Hartman, A. L., & Rogawski, M. A. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01026.x · Cited by 60
Self-citationBlock of T-Type Ca 2+ Channels Is an Important Action of Succinimide Antiabsence Drugs
Huguenard, J. R. (2002) · Epiliepsy currents/Epilepsy currents · doi:10.1111/j.1535-7597.2002.00019.x · Cited by 59
Spotlight on Levetiracetam in Epilepsy†
Lyseng-Williamson, K. A. (2011) · CNS Drugs · doi:10.2165/11208340-000000000-00000 · Cited by 59
Purines and neuronal excitability: Links to the ketogenic diet
Masino, S. A., Kawamura, M., Ruskin, D. N., Geiger, J. D., & Boison, D. (2011) · Epilepsy Research · doi:10.1016/j.eplepsyres.2011.07.014 · Cited by 59
Rogawski, M. A., Kurzman, P. S., Yamaguchi, S.-I., & Li, H. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00112-x · Cited by 56
Self-citationCullingford, T. E., Eagles, D. A., & Sato, H. (2002) · Epilepsy Research · doi:10.1016/s0920-1211(02)00011-6 · Cited by 56
Sun, G., Werkman, T. R., Battefeld, A., Clare, J. J., & Wadman, W. J. (2007) · Epilepsia · doi:10.1111/j.1528-1167.2007.01001.x · Cited by 56
Twele, F., Bankstahl, M., Klein, S., et al. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.03.014 · Cited by 55
FACTORS INFLUENCING EXPERIMENTALLY PRODUCED CONVULSIONS
Keith, H. M. (1933) · Archives of Neurology And Psychiatry · doi:10.1001/archneurpsyc.1933.02240070154009 · Cited by 55
Hadera, M. G., Smeland, O. B., McDonald, T. S., Tan, K. N., Sonnewald, U., & Borges, K. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12610 · Cited by 53
Role of GluK1 Kainate Receptors in Seizures, Epileptic Discharges, and Epileptogenesis
Fritsch, B., Reis, J., Ga̧sior, M., Kaminski, R. M., & Rogawski, M. A. (2014) · Journal of Neuroscience · doi:10.1523/jneurosci.5307-13.2014 · Cited by 52
Self-citationEffects of age and sex on the disposition of retigabine
Hermann, R., Ferron‐Brady, G., Erb, K. A., Knebel, N. G., Ruus, P., Paul, J., Richards, L. S., Cnota, H., & Troy, S. M. (2003) · Clinical Pharmacology & Therapeutics · doi:10.1067/mcp.2003.12 · Cited by 52
Neuman, R. S., Cherubini, E., & Ben‐Ari, Y. (1988) · Brain Research · doi:10.1016/0006-8993(88)90642-7 · Cited by 52
Lotarski, S. M., Donevan, S. D., El‐Kattan, A. F., Osgood, S. M., Poe, J., Taylor, C. P., & Offord, J. (2011) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.180976 · Cited by 52
Wakita, M., Kotani, N., Kogure, K., & Akaike, N. (2013) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.113.208751 · Cited by 50
Perampanel Inhibition of AMPA Receptor Currents in Cultured Hippocampal Neurons
Chen, C.-Y., Matt, L., Hell, J. W., & Rogawski, M. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108021 · Cited by 48
Self-citationThe anticonvulsant retigabine is a subtype selective modulator of GABA A receptors
Treven, M., Koenig, X., Assadpour, E., Gantumur, E., Meyer, C., Hilber, K., Boehm, S., & Kubista, H. (2015) · Epilepsia · doi:10.1111/epi.12950 · Cited by 48
Role for T-type Ca2+ channels in sleep waves
Crunelli, V., David, F., Leresche, N., & Lambert, R. C. (2014) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-014-1477-3 · Cited by 47
Nav1.1 Modulation by a Novel Triazole Compound Attenuates Epileptic Seizures in Rodents
Gilchrist, J. M., Dutton, S. B. B., Diaz-Bustamante, M., McPherson, A. J., Olivares, N. A., Kalia, J., Escayg, A., & Bosmans, F. (2014) · ACS Chemical Biology · doi:10.1021/cb500108p · Cited by 45
Functional biology of the a 2 d subunits of voltage-gated calcium channels
Davies, A., Hendrich, J., Tran-Van-Minh, A., Wratten, J., & DOLPHIN, A. C. (2007) · Cited by 42
Kv7 channels as targets for anti-epileptic and psychiatric drug-development
Grunnet, M., Strøbæk, D., Hougaard, C. Ø., & Christophersen, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.017 · Cited by 42
Levetiracetam but not valproate inhibits function of CD8+ T lymphocytes
Li, G., Nowak, M., Bauer, S., Schlegel, K., Stei, S., Allenhöfer, L., Waschbisch, A., Tackenberg, B., Höllerhage, M., Höglinger, G. U., et al. (2013) · Seizure · doi:10.1016/j.seizure.2013.03.006 · Cited by 39
Eid, T., Kovács, I., Spencer, D. D., & de Lanerolle, N. C. (2002) · European Journal of Neuroscience · doi:10.1046/j.0953-816x.2001.01887.x · Cited by 37
Levetiracetam accelerates the onset of supply rate depression in synaptic vesicle trafficking
García‐Pérez, E., Mahfooz, K., Covita, J., Zandueta, A., & Wesseling, J. F. (2015) · Epilepsia · doi:10.1111/epi.12930 · Cited by 37
Glutamate and Glutamate Receptors
Hassel, B., & Dingledine, R. J. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-374947-5.00017-1 · Cited by 36
Kim, T., Borges, K., Petrou, S., & Reid, C. A. (2012) · Epilepsy Research · doi:10.1016/j.eplepsyres.2012.09.016 · Cited by 36
Targeting SV2A for Discovery of Antiepileptic Drugs
Kaminski, R. M., Gillard, M. R., & Klitgaard, H. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0076 · Cited by 34
Visualization of SV2A conformations in situ by the use of Protein Tomography
Lynch, B. A., Matagne, A., Brännström, A., von Euler, A., Jansson, M., Hauzenberger, E., & Söderhäll, J. A. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.07.145 · Cited by 33
Targeting SV2A for discovery of antiepileptic drugs
Kaminski, R. M., Gillard, M. R., & Klitgaard, H. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02869.x · Cited by 33
Efficacy of background GABA uptake in rat hippocampal slices
Frahm, C., Engel, D., & Draguhn, A. (2001) · Neuroreport · doi:10.1097/00001756-200106130-00016 · Cited by 32
Anticonvulsant activity of phenobarbital and phenytoin in combination.
Leppik, I. E., & Sherwin, A. L. (1977) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30807-4 · Cited by 30
Trenité, D. G. A. K.-N., Brandt, C., Mayer, T., et al. (2015) · Epilepsia · doi:10.1111/epi.13008 · Cited by 30
Potassium Channels (Including KCNQ) and Epilepsy
Cooper, E. C. (2012) · Oxford University Press eBooks · doi:10.1093/med/9780199746545.003.0005 · Cited by 30
García-Pérez, E., Lo, D. C., & Wesseling, J. F. (2008) · Journal of Neurophysiology · doi:10.1152/jn.90429.2008 · Cited by 25
Englund, M., Hyllienmark, L., & Brismar, T. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9660-y · Cited by 17
Potassium channels (including KCNQ) and epilepsy
Cooper, E. C. (2010) · Epilepsia · doi:10.1111/j.1528-1167.2010.02796.x · Cited by 17
Kv7 potassium channel subunits and M currents in cultured hippocampal interneurons
Grigorov, A. O., Moskalyuk, A., Kravchenko, M., Veselovsky, N. S., Verkhratsky, A., & Fedulova, S. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1406-x · Cited by 15
Acute effects of pregabalin on the function and cellular distribution of CaV2.1 in HEK293t cells
Weissmann, C., Guilmi, M. N. D., Urbano, F. J., & Uchitel, O. D. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.10.001 · Cited by 12
The search for better epilepsy treatments: from slime mould to coconuts
Walker, M. C., & Williams, R. S. B. (2013) · Biochemical Society Transactions · doi:10.1042/bst20130183 · Cited by 11
Stuchlı́k, A., Kubová, H., & Mareš, P. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)02195-4 · Cited by 10
Cited by
Thijs, R. D., Surges, R., O'Brien, T. J., & Sander, J. W. (2019) · The Lancet · doi:10.1016/s0140-6736(18)32596-0 · Cited by 2,183
Multi-dimensional Roles of Ketone Bodies in Fuel Metabolism, Signaling, and Therapeutics
Puchalska, P., & Crawford, P. A. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2016.12.022 · Cited by 1,610
The Gut Microbiota Mediates the Anti-Seizure Effects of the Ketogenic Diet
Olson, C. A., Vuong, H. E., Yano, J. M., Liang, Q. Y., Nusbaum, D. J., & Hsiao, E. Y. (2018) · Cell · doi:10.1016/j.cell.2018.04.027 · Cited by 1,057
Löscher, W., Potschka, H., Sisodiya, S. M., & Vezzani, A. (2020) · Pharmacological Reviews · doi:10.1124/pr.120.019539 · Cited by 903
Self-citationKossoff, E. H., Zupec‐Kania, B. A., Auvin, S., Ballaban‐Gil, K. R., Christina Bergqvist, A. G., Blackford, R., Buchhalter, J. R., Caraballo, R. H., Cross, J. H., Dahlin, M. G., et al. (2018) · Epilepsia Open · doi:10.1002/epi4.12225 · Cited by 768
Self-citation
Metadata
- Authors
- Rogawski, M. A., Löscher, W., & Rho, J. M.
- Venue
- Cold Spring Harbor Perspectives in Medicine
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 2016-01-22
- Volume
- 6
- Issue
- 5
- Pages
- a022780
- ISSN
- 2157-1422 (ISSN-L)
- OpenAlex
- W2259851886
- Cited by
- 336
- References
- 195
- Type
- posted content
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.